increased glutathione in acute myeloid leukemia Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for | Current Treatment Options Oncology Targeting Aberrant Glutathione Metabolism to
Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells ScienceDirect Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia ScienceDirect Glutamine and leukemia research: progress and clinical prospects Discover Oncology Springer Nature Link Metabolic reprogramming and immune regulation in acute myeloid leukemia Frontiers Crosstalk between autophagy and metabolism: implications for cell survival in acute myeloid leukemia Cell Death Discovery ABCC1 and glutathione metabolism limit the efficacy of BCL 2 inhibitors in acute myeloid leukemia Nature Communications
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





